The main alterations of CKD–MBD encompass hyperphosphatemia, hypocalcemia, low serum levels of vitamin D, and an increased secretion of parathyroid hormone (PTH) from the parathyroid glands (secondary hyperparathyroidism, SHPT). This evidence concerns the gene PTH and secondary hyperparathyroidism.